{
  "actions": [
    {
      "acted_at": "2019-09-19", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2019-09-19", 
      "action_code": "H11100", 
      "committees": [
        "HSJU"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on the Judiciary.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2019-10-02", 
      "action_code": "", 
      "committees": [
        "HSJU"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr4398-116", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU", 
      "subcommittee": "Subcommittee on Antitrust, Commercial, and Administrative Law", 
      "subcommittee_id": "05"
    }
  ], 
  "congress": "116", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2019-09-19", 
  "number": "4398", 
  "official_title": "To amend the Federal Trade Commission Act to prohibit anticompetitive behaviors by drug product manufacturers, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s1416-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Affordable Prescriptions for Patients Through Promoting Competition Act of 2019", 
  "sponsor": {
    "bioguide_id": "C001084", 
    "district": "1", 
    "name": "Cicilline, David N.", 
    "state": "RI", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2019-09-19", 
  "subjects": [
    "Administrative remedies", 
    "Civil actions and liability", 
    "Commerce", 
    "Competition and antitrust", 
    "Consumer affairs", 
    "Federal Trade Commission (FTC)", 
    "Health care costs and insurance", 
    "Inflation and prices", 
    "Intellectual property", 
    "Judicial review and appeals", 
    "Manufacturing", 
    "Prescription drugs"
  ], 
  "subjects_top_term": "Commerce", 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Federal Trade Commission Act to prohibit anticompetitive behaviors by drug product manufacturers, and for other purposes.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Affordable Prescriptions for Patients Through Promoting Competition Act of 2019", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Affordable Prescriptions for Patients Through Promoting Competition Act of 2019", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Affordable Prescriptions for Patients Through Promoting Competition Act of 2019", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-10-03T12:27:46Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr4398.xml"
}